Quick Search

 

 


 

 

Result Summary for AZL30006

Result Summary
Protocol ID: AZL30006
Clinical Study ID: AZL30006
Official Title: See Detailed Description
Phase: Phase 3
Study Indications or Diseases:
  • Infection, Human Immunodeficiency Virus
Generic Name: abacavir/lamivudine/zidovudine
Trade/Product Name: lexiva;lexiva
Approved Drug Label: http://www.gsk.com/products.html
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.